Proof-of-concept study for SAR441344 (frexalimab) in relapsing multiple sclerosis.

Authors
Category Primary study
Registry of TrialsClinical Trials Information System
Year 2026
This article has no abstract
Epistemonikos ID: aaa22a4a15f974980ab72721477896b07b561ccc
First added on: Jan 17, 2026